Tae Hoon Chung

Cancer Science Institute of Singapore, National University of Singapore

Singapore

Research Interests

Explore related searches

Professors in Cancer Biology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Siok-Bian Ng

Associate Professor

National University of Singapore (NUS)

SINGAPORE

View details

Melissa Ooi

Assistant Professor of Medicine

National University of Singapore (NUS)

SINGAPORE

View details

Mun Yee Koh

Cancer Science Institute of Singapore, National University of Singapore

SINGAPORE

View details

Nurulhuda Mustafa

National University of Singapore

SINGAPORE

View details

Aaron Leow

Cancer Science Institute of Singapore, National University of Singapore

SINGAPORE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tae Hoon Chung

Research Interests

Explore related searches

Contact this professor

Articles (8)

The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma

Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma

Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma

T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes

Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma.

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma.

Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL.

Frequent upregulation of G9a promotes RelB-dependent proliferation and survival in multiple myeloma.

Collaborators (5)

Siok-Bian Ng

Melissa Ooi

Mun Yee Koh

Nurulhuda Mustafa

Aaron Leow

Make your next move.